Framingham Heart Study: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett (Created page with "{{subpages}} In epidemiology, the '''Framingham Heart Study''' was a cohort study that started in 1948 for the objective of:<ref>[http://www.framinghamheartstudy.org/abou...") |
imported>Robert Badgett No edit summary |
||
| Line 9: | Line 9: | ||
* [[Framingham risk score]] | * [[Framingham risk score]] | ||
* [[Framingham congestive-heart-failure score]] | * [[Framingham congestive-heart-failure score]] | ||
* [http://www.framinghamheartstudy.org/risk/atrial.html Framingham atrial fibrillation risk] | |||
==References== | ==References== | ||
<references/> | <references/> | ||
Revision as of 21:49, 7 July 2011
In epidemiology, the Framingham Heart Study was a cohort study that started in 1948 for the objective of:[1]
- "The objective of the Framingham Heart Study was to identify the common factors or characteristics that contribute to CVD by following its development over a long period of time in a large group of participants who had not yet developed overt symptoms of CVD or suffered a heart attack or stroke."
The study was sponsored by the National Heart, Lung, and Blood Institute of the National Institutes of Health.
Research that has emerged from the study includes: